News

When Coca-Cola fully took control of BodyArmor in 2021 in a $5.6 billion deal, the company had the goal of it “becoming the #1 global sports drink,” toppling PepsiCo’s Gatorade from its top-selling ...
UBS analyst Peter Grom raised the firm’s price target on Coca-Cola to $84 from $78 and keeps a Buy rating on the shares as part of a Q1 preview ...